Member Info for Brondby

Good call Henners and perfect timing. People will get suspicious ;-)

50% discount a very good deal for placees. Company now worth less than its assets. Better news will have been held back to shift these shares.

Shareholders, as now seems the norm, shafted.

Maybe. But there is a buyer in the 2.2p to 2.3p range that seems more confident of more positive outcome.

I've frequently been getting sell quotes that are higher than my buy quotes.

Regulatory approvals in EU and USA were on track for the end of 2025 according to the last but one RNS.

Other commercial alternatives may also exist other than a straight raise. We'll see. Risky, but given how far this has fallen, there is real potential for a recovery play here. High risk, high reward. Place your bets.

And as if by magic, we're on our way up again, and board has suddenly got an awful lot quieter.

Yep. And the price volume trend is telling a very different story to the doom and gloom posters here.

The flurry of negative posts coinciding with a significant support level is usually the bottom. If they can't break the support, they switch to buy.

Unfortunately, waiting creates the time and space for FUDsters to flourish.

Or is it groundhog day?

So is the buying, it would seem

"Well the share price could at least stay flat or go up whilst waiting for the news"

Are you new to AIM?

Congratulations on your first ever LSE board post tilitingwindmills 🍾

Taser, nobody asked you why you exited.

They asked why you felt the need to tell anyone 🤷‍♂️

Nobody but you cares.

With such a large order book, global potential, quality product and a small market cap, this must surely be a candidate for a swift takeover?

Really doesn't feel high risk at all. They clearly have a very good product. High risk is speculative oil or gold (which I do also invest in).

Yes they have to execute, but so does every other company.

Huge demand for rapid builds globally. SIt back and watch it grow.

Bought a chunk to sit in my ISA.

Easily make up that 45%, and 100s more on good assays.

Only sellers care what the price is short-term.

The assays will determine the future, one way or another. So pointless to worry about it until then.

MMs will drop it to encourage trades (on which they make their margins).

Standardti see price drop while waiting on assays, drill results, etc. and a board full of deprampers and FUD spreaders mean plenty are interested in buying in here more cheaply.

You're either IN or OUT. Make the choice and wait for assays.

I noticed that since the OTC listing, the hamak share price chart no longer appears when searching for 'hamak share price' 'lse:hama', etc. in google

In google Finance itself, you can find hamak listed only under its $ OTC listing.

No inconvenience for many here, but I do think this is a hinderance for the wider investment community.

Anyone able to find it in google Finance? If you had it on a google finance watchlist, is it still there?

Mine in HL and not showing

Paul, if you dont know the answer to my question, stop posting on this thread. Thanks

...before assay results do we think?

Well we know there wil be news coming. Its been flagged. Its what that news is that will be important.

Meantime, you just have to wait as the MM drop the bid on low volume and try to extract as many shares as possible from traders operating on stop loss strategies. Its a well worn script across the small cap market. A bit tedious, but all part of the game. I'm buying as we drop.

Does this work for you?

https://archive.is/2025.08.19-090019/https://www.yorkshirepost.co.uk/business/cizzle-biotechnology-this-is-how-york-university-spin-out-aims-to-cut-lung-cancer-deaths-worldwide-5275671

Https://www.cizzlebio.com/events

New events added here recently (not monitoring closely enough to know exactly when, but most of the 2025 events were not there last time I looked)

Bio at 17th Annual Next Generation Dx Summit this week in Washington DC.

Other events in Washington and New York in Sep/Oct.

This one caught my eye:

"Cizzle Bio will attend the 15th Annual AVBCC Summit in New York City from October 22–24, 2025. Our CEO, Bill Behnke, will moderate a panel on advancing cancer diagnostics to commercialization."

Brought to mind the recent event when Syms chaired an event on fundraising for BioTech, on the day ciz announced funding to progress the test in UK/Europe.

Also noted two new sections on website, one "For Patients", the other "For Physicians", bith marked "Coming Soon". Again don't know when they appeared, but waybackmachine suggests in the last month.

Yes Greend100, my understanding is they can close the crowdfunding at any time between now and the "end date" next year, as the minimim target amount was only $10k and has already been reached.

They have 7 major cancer centres across multiple states doing clinical trials. This is being taken very seriously indeed.

I find the current selling baffling, and exploited by MMs to drop price on low volume. Verge of launch. Major cancer centres involved. Funds raised recently to progress in Europe and UK.

I understand the concerns over comms, but really, a running commentary of operations isn't going to change the outcome. You'd just turn the sp into a roller coaster as good/bad news updates are released (maybe that is what some here want)

My view is just let them get on with it. The shares are not going to be worth anything sensible until takeover/buy out/revenues. So shut the lid until that point.

What an entry point for latecomers, IMO.

GLA